Alaunos Therapeutics (TCRT) Preferred Dividend Payments (2016 - 2018)

Alaunos Therapeutics (TCRT) has 3 years of Preferred Dividend Payments data on file, last reported at $342000.0 in Q4 2018.

• Quarterly Preferred Dividend Payments fell 93.16% year-over-year to $342000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $17.0 million (down 10.24% YoY) and the FY2018 annual result came in at $17.0 million, down 10.24% from the prior year.
• Preferred Dividend Payments fell to $342000.0 in Q4 2018, from $6.1 million in the prior quarter.
• In the past five years, Preferred Dividend Payments ranged from a high of $6.1 million in Q3 2018 to a low of $342000.0 in Q4 2018.
• A 3-year average of $4.3 million and a median of $4.9 million in 2017 frame the typical range for Preferred Dividend Payments.
• Annual changes were most pronounced in 2017 — Preferred Dividend Payments jumped 41.53% — and 2018, when it sank 93.16%.
• Tracing TCRT's Preferred Dividend Payments over 3 years: stood at $3.5 million in 2016, then soared by 41.53% to $5.0 million in 2017, then slumped by 93.16% to $342000.0 in 2018.
• The last three Preferred Dividend Payments figures came in at $342000.0 (Q4 2018), $6.1 million (Q3 2018), and $5.5 million (Q2 2018), per Business Quant data.